Sales Growth Leaves Analysts Bullish On Cubist’s Cubicin
This article was originally published in The Pink Sheet Daily
Executive Summary
Injectable antibiotic continues to pry away market share from generic vancomycin.
You may also be interested in...
Cubist Gets Entereg And A Late-Stage Compound With Adolor Buy
The deal includes a contingent payment right tagged to Phase III-ready constipation drug ADL5945 that will provide extra consideration for Adolor shareholders if the drug reaches its upside potential.
Cubist Gets Entereg And A Late-Stage Compound With Adolor Buy
The deal includes a contingent payment right tagged to Phase III-ready constipation drug ADL5945 that will provide extra consideration for Adolor shareholders if the drug reaches its upside potential.
Deals Of The Week: UCB/Wilex, J&J/Vanderbilt, Alnylam/Cubist ...
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.